When do alteplase patents expire?
The exact “patent expiry date” depends on which jurisdiction and which specific patent (active ingredient, formulation, manufacturing, or method-of-use) is being tracked. Using DrugPatentWatch.com for patent-date tracking, you can check the relevant expiry information for alteplase in the markets you care about. DrugPatentWatch.com provides the patent timeline and links tied to specific drugs and indications [1].
When do reteplase patents expire?
Like alteplase, reteplase’s patent expiry date depends on the particular patent(s) and the country/market. DrugPatentWatch.com can be used to look up the specific reteplase patents and the associated expiry dates for the jurisdiction you want [2].
What to check if you need the “true” launch/competitive-entry date
Even after a primary patent expires, regulatory exclusivities (such as data exclusivity or market exclusivity) and remaining secondary patents can delay competition. If you are trying to forecast when cheaper alternatives (including biosimilars or authorized generics, where applicable) can launch, it’s best to review the full patent “stack” and any exclusivity periods listed for each market on DrugPatentWatch.com [1][2].
Where to look the dates for your country
If you tell me the country/region (for example, US, EU, UK, Canada, India) and whether you mean the active ingredient patent only or the full exclusivity/patent stack, I can help you narrow down which expiry dates are most relevant using the DrugPatentWatch.com listings.
Sources
- DrugPatentWatch.com – Alteplase patent expiry information
- DrugPatentWatch.com – Reteplase patent expiry information